Dynamics of minimal residual disease in patients with multiple myeloma on continuous lenalidomide maintenance: a single-arm, single-centre, phase 2 trial

Publication date: June 2021Source: The Lancet Haematology, Volume 8, Issue 6Author(s): Benjamin Diamond, Neha Korde, Alexander M Lesokhin, Eric L Smith, Urvi Shah, Sham Mailankody, Malin Hultcrantz, Hani Hassoun, Sydney X Lu, Carlyn Tan, Even H Rustad, Francesco Maura, Kylee Maclachlan, Tim Peterson, Andriy Derkach, Sean Devlin, Heather J Landau, Michael Scordo, David J Chung, Gunjan L Shah

Source: The Lancet Haematology - May 26, 2021 Category: Hematology Source Type: research